Relationship between dyskerin expression and telomerase activity in human breast cancer

Cellular Oncology

Volumn 30, Issue 6, 2008, Pages 483-490

  Montanaro, Lorenzo ^a   Calienni, Maria ^a   Ceccarelli, Claudio ^a   Santini, Donatella ^a   Taffurelli, Mario ^a   Pileri, Stefano ^a   Treré, Davide ^a   Derenzini, Massimo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Breast carcinomas; Dyskerin; Telomerase; TERC; TERT

Indexed keywords

DYSKERIN; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; BIOGENESIS; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOME;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TELOMERASE; TRANSFECTION;

EID: 54249168541     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/830562     Document Type: Article

References (24)

1. I. Dokal, Dyskeratosis congenita in all its forms, Br. J. Haematol. 110 (2000), 768-779.
2. U.T. Meier, The many facets of H/ACA ribonucleoproteins, Chromosoma 114 (2005), 1-14.
3. C. Wang, C.C. Query and U.T. Meyer, Immunopurified small nucleolar ribonucleoprotein particles pseudouridylate rRNA independently of their association with phosphorylated Nopp140, Mol. Cell. Biol. 22 (2002), 8457-8466.
4. J.R. Mitchell, E. Wood and K. Collins, A telomerase component is defective in the human disease dyskeratosis congenita, Nature 402 (1999), 551-555.
5. J.M. Wong and K. Collins, Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita, Gen. Dev. 20 (2006), 202848-202858.
6. D. Ruggero, S. Grisendi, F. Piazza, E. Rego, F. Mari, P.H. Rao, C. Cordon-Cardo and P.P. Pandolfi, Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification, Science 299 (2003), 259-262.
7. A. Yoon, G. Peng, Y. Brandenburger, O. Zollo, W. Xu, E. Rego and D. Ruggero, Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita, Science 312 (2006), 902-906.
8. D. Ruggero and P.P. Pandolfi, Does ribosome translate cancer?, Nat. Rev. Cancer 3 (2003), 179-192.
9. L. Montanaro, M. Brigotti, J. Clohessy, S. Barbieri, C. Ceccarelli, D. Santini, M. Taffurelli, M. Calienni, J. Teruya-Feldstein, D. Trere, P.P. Pandolfi and M. Derenzini, Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer, J. Pathol. 210 (2006), 10-18.
10. C. Poremba, B. Heine, R. Diallo, A. Heinecke, D. Wai, K.L. Schaefer, Y. Braun, A. Schuck, C. Lanvers, A. Bànkfalvi, S. Kneif, J. Torhorst, M. Zuber, O.R. Köchli, F. Mross, H. Dieterich, G. Sauter, H. Stein, F. Fogt and W. Boecker, Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR, J. Pathol. 198 (2002), 181-189.
11. M. Kimura, T. Koida and Y. Yanagita, A study on telomerase activity and prognosis in breast cancer, Med. Oncol. 20 (2003), 117-126.
12. J.C. Poole, L.G. Andrews and T.O. Tollefsbol, Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT), Gene 269 (2001), 1-12.
13. G. Saretzki, Telomerase inhibition as cancer therapy, Cancer Lett. 194 (2003), 209-219.
14. E.A. Janssen, P.J. van Diest, H. Søiland, E. Gudlaugson, A. Nysted, F.J. Voorhorst, J.B. Vermorken, J.A. Søreide and J.P. Baak, Success predictors of adjuvant chemotherapy in node-negative breast cancer patients under 55 years, Cell. Oncol. 28 (2006), 295-303.
15. C.H. van Deurzen, R. van Hillegersberg, M.G. Hobbelink, C.A. Seldenrijk, R. Koelemij and P.J. van Diest, Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases, Cell. Oncol. 29 (2007), 497-505.
16. T. Yajima, A. Yagihashi, H. Kameshima, D. Kobayashi, D. Furuya, K. Hirata and N. Watanabe, Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system, Clin. Chem. 44 (1998), 2441-2445.
17. B.S. Herbert, A.E. Hochreiter, W.E. Wright and J.W. Shay, Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol, Nature Protocols 1 (2006), 1583-1590.
18. H. Hisatomi, K. Nagao, T. Kanamaru, H. Endo, M. Tomimatsu and K. Hikiji, Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy, Int. J. Oncol. 14 (1999), 727-732.
19. Y. Zhu, R.L. Tomlinson, A.A. Lukowiak, R.M. Terns and M.P. Terns, Telomerase RNA accumulates in Cajal bodies in human cancer cells, Mol. Biol. Cell 15 (2004), 81-90.
20. T. Oshita, N. Nagai and K. Ohama, Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer, Int. J. Oncol. 17 (2000), 1225-1230.
21. K.L. Kirkpatrick, G. Clark, M. Ghilchick, R.F. Newbold and K. Mokbel, hTERT mRNA expression correlates with telomerase activity in human breast cancer, Eur. J. Surg. Oncol. 9 (2003), 321-326.
22. J.H. Ohyashiki, H. Hisatomi, K. Nagao, S. Honda, T. Takaku, Y. Zhang, G. Sashida and K. Ohyashiki, Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells, Br. J. Cancer 92 (2005), 1942-1947.
23. R. Tomoda, M. Seto, H. Tsumuki, K. Iida, T. Yamazaki, J. Sonoda, A. Matsumine and A. Uchida, Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors, Cancer 95 (2002), 1127-1133.
24. T. Kanaya, S. Kyo, M. Takakura, H. Ito, M. Namiki and M. Inoue, hTERT is a critical determinant of telomerase activity in renal-cell carcinoma, Int. J. Cancer 78 (1998), 539-543.